IQVIA Supports Sites And Participants Through Patient-Centric Trial Experiences

In this interview, Eric Klaver, IQVIA's DCT regulatory director, discusses how IQVIA supports investigators in decentralized clinical trials (DCT) compliance and operations. IQVIA, a global leader in analytics technology and clinical research services for the life sciences industry, facilitates patient-centric care in trials through elements like remote pre-screening, telemedicine visits, and mobile research nurses. While the industry is integrating DCT elements into current practices rather than a major shift, IQVIA emphasizes the importance of considering regulations on system security, privacy, and confidentiality during implementation. With trained staff tailored to site and study needs, IQVIA offers specialized resources to manage clinical trial tasks efficiently. Understanding decentralized elements enhances familiarity and promotes a personalized, patient-centric trial experience. Listen below.